Lexaria Bioscience CORP. (LEXX) SEC Filings — 2025

Filings

• Lexaria Bioscience Files 8-K on Material Agreement & Equity Sales — 8-K · Dec 16, 2025
• Lexaria Bioscience Sets Jan 27 Shareholder Meeting; Board, Auditor Votes Loom — DEF 14A · Dec 10, 2025
• Lexaria Files S-1/A for Resale of 2.76M Shares, Highlights DehydraTECH Progress — S-1/A · Dec 5, 2025
• Lexaria Bioscience R&D Surges to $8.2M, Bolstering DehydraTECH Patents — 10-K · Nov 28, 2025
• Lexaria Files S-1 for Resale of 2.76M Shares; DehydraTECH Shows Promise — S-1 · Oct 14, 2025
• Lexaria Bioscience Files 8-K: Material Agreement, Equity Sales — 8-K · Sep 29, 2025
• Lexaria Bioscience Terminates Material Agreement — 8-K · Sep 25, 2025
• Lexaria Narrows Q3 Loss Amid Capital Raising Efforts — 10-Q · Jul 14, 2025
• Lexaria Bioscience Corp. Signs Material Definitive Agreement — 8-K · Jun 12, 2025
• Lexaria Bioscience Files 8-K on Material Agreement & Equity Sales — 8-K · Apr 28, 2025
• Lexaria Bioscience R&D Surges in Q2 2025 — 10-Q · Apr 14, 2025
• Lexaria Bioscience Corp. Files 8-K with Material Agreement — 8-K · Feb 5, 2025
• Lexaria Bioscience Corp. Files 8-K on Shareholder Vote Matters — 8-K · Jan 15, 2025
• Lexaria Bioscience Q1 Revenue Drops, Expenses Rise — 10-Q · Jan 10, 2025
• Lexaria Bioscience Corp. Reports Director and Officer Changes — 8-K · Jan 3, 2025